mizacorat (AZD9567) / AstraZeneca  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
mizacorat (AZD9567) / AstraZeneca
NCT03368235 / 2017-000838-64: Early Phase Study to Assess Efficacy and Safety of AZD9567 Versus Prednisolone in Patients With Rheumatoid Arthritis

Completed
2a
21
Europe
AZD9567, Prednisolone
AstraZeneca
Rheumatoid Arthritis
11/19
11/19
NCT04556760 / 2020-000931-35: Study to Assess the Effect on Glucose Homeostasis of Two Dose Levels of AZD9567, Compared to Prednisolone, in Adults With Type 2 Diabetes

Completed
2
46
Europe
AZD9567, Prednisolone, Placebo
AstraZeneca, Parexel
Diabetes Mellitus, Type 2
06/21
06/21

Download Options